Prasol Chemicals

Founded in 1992, Prasol Chemicals has evolved into a significant player in the Indian specialty chemicals landscape. Over three decades, the company has built a robust portfolio comprising more than 150 specialty chemicals, categorized into 21 acetone-based, 53 phosphorus-based, and 76 other complex chemical formulations.

The company's business model focuses on catering to high-growth industrial segments. Its products are essential inputs for performance chemicals like lubricants and mining additives, as well as the PICA sector (paints, inks, construction, and adhesives). Furthermore, it provides critical chemical components for the pharmaceutical and agrochemical industries, as well as home and personal care products.

Prasol Chemicals maintains a strong market position with a global reach, exporting its products to 69 countries. Its client roster includes industry leaders such as Alembic Pharmaceuticals, Lubrizol India, Rossari Biotech, Clean Science, Gharda Chemicals, Croda India, Supriya Lifescience, and Yasho Industries, serving a total of 1,600 customers.

Operationally, the company scales its production through two major manufacturing facilities located in Khopoli and Mahad, spanning 1,20,604 sq. m. and 1,19,423 sq. mt. respectively. This infrastructure allows for the diverse manufacturing requirements of its complex chemical range.

The company is led by a group of promoters including Nishith Rajnikant Shah, Gaurang Natwarlal Parikh, and Dhaval Nalin Parikh, among others, who have steered the company's growth from a domestic manufacturer to a global exporter.

The Prasol Chemicals IPO is a mainboard issue totaling approximately ₹500 crore, consisting of a fresh issue of ₹80 crore and an Offer for Sale (OFS) of approximately 62,13,006 equity shares. The price band is set between ₹643 and ₹676 per share, with a minimum retail lot size of 22 shares requiring an application amount of ₹14,872. The issue opens on September 8, 2026, and closes on September 10, 2026, with listing scheduled for September 16, 2026, on both the BSE and NSE.

Proceeds from the fresh issue are primarily earmarked for the repayment or prepayment of certain borrowings, amounting to ₹60.00 crore, highlighting a focus on deleveraging the balance sheet. The remaining portion is allocated toward general corporate purposes.

Financial performance indicates a strong upward trajectory. Revenue grew from ₹887.56 crore in FY24 to ₹1,015.54 crore in FY25, reaching ₹1,237.85 crore in FY26. More impressively, the Profit After Tax (PAT) showed exponential growth, rising from ₹18.13 crore in FY24 to ₹43.57 crore in FY25, and jumping to ₹83.12 crore in FY26.

From a valuation perspective, the company reports a Basic EPS of ₹14.33 and a Net Asset Value (NAV) of ₹77.33. While a specific P/E ratio was not provided, the company's operational KPIs are strong, featuring an ROE of 20.37% and a ROCE of 22.43%, indicating efficient capital utilization compared to several industry peers.

Key strengths include a diversified product portfolio, an extensive global export footprint, and a low debt-to-equity ratio of 0.19. However, investors should note that 84% of the issue is an Offer for Sale, meaning the majority of the proceeds go to selling shareholders rather than the company's growth.

Overall, Prasol Chemicals presents a fundamentally strong profile with accelerating profitability. While the high OFS component may dampen short-term sentiment, the company's growth metrics and lean debt profile make it an interesting prospect for long-term investors.